Why Is Cardinal Health Stock Gaining Tuesday? - Cardinal Health (NYSE:CAH)

Core Viewpoint - Cardinal Health, Inc. has raised its fiscal 2026 earnings outlook, projecting non-GAAP diluted earnings per share to be at least $10, up from a previous range of $9.65 to $9.85, indicating improved operational performance [1] - The company expects Specialty revenues to exceed $50 billion during fiscal 2026, representing a 16% compounded annual growth rate over three years [2] Medicare Pricing Transition - Cardinal Health successfully transitioned pharmaceutical distribution agreements affected by the Medicare Drug Price Negotiation Program changes ahead of implementation, ensuring appropriate compensation for its distribution services [3] - The company introduced the ContinuCare Pathway program under its at-Home Solutions business to simplify diabetes supply management and insurance navigation for patients and partner pharmacies [4] Broad Business Scope - Cardinal Health is a major distributor of pharmaceuticals, specialty products, and medical and laboratory supplies, also providing performance solutions and direct-to-patient services across the healthcare sector [5] - At the time of publication, Cardinal Health shares rose by 4.08% to $210.77, trading near its 52-week high of $214.93 [5]